Cardiovascular Risk and Sudden Cardiac Death in Diabetes

Rising Sudden Cardiac Death (SCD) Risk in Type 1 and Type 2 Diabetes

A new Danish nationwide cohort study sheds light on a critical, and often underestimated, threat: sudden cardiac death in diabetes. The findings indicate that individuals with Type 1 diabetes (T1D) and Type 2 diabetes (T2D) experience substantially higher rates of sudden cardiac death (SCD), along with years of life lost, compared with the general population. For clinicians and nurses, these results underscore the need for sharpened risk assessment and earlier prevention strategies.

Explore All Endocrinology CME/CE Conferences and Online Courses

Elevated Sudden Cardiac Death (SCD) Rates and Younger Age of Onset

The research, published in the European Heart Journal, analyzed all deaths in Denmark in 2010, representing a population of 5.5 million. Of the 54,028 deaths that year, 12.7% were classified as sudden cardiac death. Among individuals with diabetes, 97 SCD cases occurred in T1D and 1,149 in T2D.

Key epidemiologic insights include:

• Sudden Cardiac Death incidence per 100,000 person-years:
  • 394 in T1D
  • 681 in T2D
  • 105 in the general population

• Younger onset: SCD patients with diabetes were generally younger and more often male.
• Higher comorbidity burden: Higher rates of ischaemic heart disease, arrhythmias, cardiomyopathy, heart failure, and microvascular complications were observed in both diabetes groups.
• Hypoglycemia-related risk: Prior severe hypoglycemia was present in 37% of T1D-SCD cases and 7.2% of T2D-SCD cases.

These findings highlight that patients with diabetes face a 3.7-fold (T1D) and 6.5-fold (T2D) higher SCD risk even after adjusting for cardiovascular comorbidities.

Understanding the Life-Years Lost and Clinical Impact

Life expectancy modeling from age 30 revealed:

• T1D: 14.2 years lost, of which 3.4 years are due to SCD
• T2D: 7.9 years lost, with 2.7 years attributed to SCD

Although absolute SCD rates are higher in T2D, the relative risk is most significant in younger T1D adults, particularly those aged 30–40 years (22.7× higher than age-matched controls).

For clinicians, these results emphasize the need to broaden SCD prevention beyond traditionally high-risk cardiovascular populations and incorporate diabetes-specific triggers, including hypoglycemia and early vascular disease.

Strengthening Early Detection and Risk Prevention in Diabetes Care

This study provides clear evidence that sudden cardiac death represents a significant, quantifiable contributor to reduced life expectancy in diabetes, reinforcing the need for:

• earlier risk stratification
• structured SCD prevention protocols
• monitoring for hypoglycemia-associated cardiac risk
• multidisciplinary intervention for cardiometabolic comorbidity

Healthcare professionals can apply these insights to refine clinical decision-making and proactively identify patients needing more targeted monitoring and prevention.

Source:

Oxford Academic